“…Nevertheless, current adhesion-prevention strategies are largely limited to mechanical barriers, such as oxidized regenerated cellulose (Gynecare Interceed, Ethicon, Inc., Somerville, NJ) or sodium hyaluronate with carboxymethylcellulose (Saprafilm, Genzyme, Inc., Cambridge, MA). While the effectiveness of these barrier agents in clinical practice remains inconsistent (7-9) other studies indicate that limiting inflammatory processes and/or angiogenesis may provide efficacy in reducing adhesion formation (10-12). …”